361 related articles for article (PubMed ID: 26385705)
1. Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still's disease.
Han JH; Suh CH; Jung JY; Nam JY; Kwon JE; Yim H; Kim HA
Arthritis Res Ther; 2015 Sep; 17(1):260. PubMed ID: 26385705
[TBL] [Abstract][Full Text] [Related]
2. Histopathology and expression of the chemokines CXCL10, CXCL13, and CXCR3 and the endogenous TLR-4 ligand S100A8/A9 in lymph nodes of patients with adult-onset Still's disease.
Kim HA; Kim YH; Jeon YK; Yang WI; Kwon JE; Han JH
Sci Rep; 2019 May; 9(1):7517. PubMed ID: 31101882
[TBL] [Abstract][Full Text] [Related]
3. TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical Manifestations.
Kim HA; Han JH; Kim WJ; Noh HJ; An JM; Yim H; Jung JY; Kim YS; Suh CH
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537874
[TBL] [Abstract][Full Text] [Related]
4. Elevated circulating levels of the interferon-γ-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still's disease.
Han JH; Suh CH; Jung JY; Ahn MH; Han MH; Kwon JE; Yim H; Kim HA
Sci Rep; 2017 Apr; 7():46652. PubMed ID: 28436448
[TBL] [Abstract][Full Text] [Related]
5. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
J Rheumatol; 2004 Nov; 31(11):2189-98. PubMed ID: 15517632
[TBL] [Abstract][Full Text] [Related]
6. Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease.
Han JH; Suh CH; Jung JY; Ahn MH; Kwon JE; Yim H; Kim HA
J Rheumatol; 2017 Jun; 44(6):740-747. PubMed ID: 28365573
[TBL] [Abstract][Full Text] [Related]
7. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
Arthritis Rheum; 2005 Jun; 53(3):320-7. PubMed ID: 15934126
[TBL] [Abstract][Full Text] [Related]
8. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY; Wen MC
Ann Rheum Dis; 2004 Oct; 63(10):1300-6. PubMed ID: 15361391
[TBL] [Abstract][Full Text] [Related]
9. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
[TBL] [Abstract][Full Text] [Related]
10. Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study.
Han BK; Kuzin I; Gaughan JP; Olsen NJ; Bottaro A
Arthritis Res Ther; 2016 Apr; 18():93. PubMed ID: 27102921
[TBL] [Abstract][Full Text] [Related]
11. The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset Still's disease.
Han JH; Ahn MH; Jung JY; Suh CH; Kwon JE; Yim H; Kim HA
Clin Exp Rheumatol; 2019; 37 Suppl 121(6):67-73. PubMed ID: 31287410
[TBL] [Abstract][Full Text] [Related]
12. H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease.
Ruscitti P; Cipriani P; Ciccia F; Di Benedetto P; Liakouli V; Berardicurti O; Carubbi F; Guggino G; Di Bartolomeo S; Triolo G; Giacomelli R
Clin Exp Immunol; 2016 Oct; 186(1):30-8. PubMed ID: 27317930
[TBL] [Abstract][Full Text] [Related]
13. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
Kim HA; An JM; Nam JY; Jeon JY; Suh CH
J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma galectin-3 levels and their correlation with disease activity in adult-onset Still's disease.
Chen PK; Lan JL; Li JP; Chang CK; Chang SH; Huang PH; Yeo KJ; Chen DY
Clin Rheumatol; 2020 Jun; 39(6):1945-1952. PubMed ID: 31960208
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus Infection May Trigger Adult-Onset Still's Disease Onset or Relapses.
Jia J; Shi H; Liu M; Liu T; Gu J; Wan L; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Gong W; Yang C; Hu Q
Front Immunol; 2019; 10():898. PubMed ID: 31068953
[TBL] [Abstract][Full Text] [Related]
16. Characteristic patterns of HLA presentation and T cell differentiation in adult-onset Still's disease.
Jung JY; Choi B; Sayeed HM; Suh CH; Kim YW; Kim HA; Sohn S
Int J Immunopathol Pharmacol; 2018; 32():2058738418791284. PubMed ID: 30052100
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.
Chi H; Liu D; Sun Y; Hu Q; Liu H; Cheng X; Ye J; Shi H; Yin Y; Liu M; Wu X; Zhou Z; Teng J; Yang C; Su Y
Arthritis Res Ther; 2018 Mar; 20(1):54. PubMed ID: 29566725
[TBL] [Abstract][Full Text] [Related]
18. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease.
Bae CB; Suh CH; An JM; Jung JY; Jeon JY; Nam JY; Kim HA
J Rheumatol; 2014 Dec; 41(12):2403-8. PubMed ID: 25274901
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Disturbances in Adult-Onset Still's Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis.
Chen DY; Chen YM; Chien HJ; Lin CC; Hsieh CW; Chen HH; Hung WT; Lai CC
PLoS One; 2016; 11(12):e0168147. PubMed ID: 28005947
[TBL] [Abstract][Full Text] [Related]
20. The Role of RIPK1/3 in Adult Onset Still's Disease Patients With Liver Damage: A Preliminary Study.
Liu X; Guo R; Meng X; Fang J; Lu L
Front Immunol; 2020; 11():560744. PubMed ID: 33329521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
